Last reviewed · How we verify

NCT05449080

Disorders of Sex Development (DSD) 46.XY in Three Siblings

Completed Last updated 8 July 2022
What this trial tests

trial testing Karyotype in Genotype in 3 participants. Completed in 31 December 2021.

Timeline
1 October 2021
Primary endpoint
1 December 2021
31 December 2021

Quick facts

Lead sponsorUniversitas Padjadjaran
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3
Start date1 October 2021
Primary completion1 December 2021
Estimated completion31 December 2021
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Universitas Padjadjaran — full company profile →

Who can join

Eligibility, female only, with Genotype. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a case series of three siblings with DSD 46,XY with relevant discussion

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Disorders of sex development (DSD) 46.XY due to type 2 5-α reductase deficiency in three siblings: Case report from a low-resource setting.
    Putri Susilo AF, Tjandraprawira KD, Bayu P, Bayuaji H. · · 2022 · cited 1× · PMID 36268297 · DOI 10.1016/j.amsu.2022.104577

Verify or expand the search:

Other recruiting trials for Genotype

Currently open trials in the same condition.

Other Universitas Padjadjaran trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05449080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing